Aldebaran Therapeutics, Inc. — Form D
Aldebaran Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-28. The offering totals $1.2M, of which $800K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-28
- Form: D
- Accession: 0001918979-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $800K
- Remaining: $400K
- Investors: 20
- Date of first sale: 2022-02-09
- Revenue range: Decline to Disclose
- SEC file number: 021-439130
Issuer
- Name: Aldebaran Therapeutics, Inc.
- CIK: 0001918979
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 275 SECOND AVE, WALTHAM, MA, 02451
- Phone: 617-203-7118
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Carlos Loya | Director | Waltham, MA |
| Lauren Mifflin | Director | Waltham, MA |
| Chris Pacheco | Director | Waltham, MA |
| Carlos Loya | Executive Officer | Waltham, MA |
More